시장보고서
상품코드
1831653

등온 핵산 증폭 기술(INAAT) 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 예측(2025-2034년)

Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagent), By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 114 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 등온 핵산 증폭 기술 시장 규모는 2034년까지 180억 4,000만 달러에 이를 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

INAAT로 알려진 등온 핵산 증폭 기술은 단일 일정 온도에서 다수의 DNA 또는 RNA 사본을 생성하는 분자 생물학적 기술 그룹입니다. 가열과 냉각의 반복을 필요로 하는 기존의 방법과는 달리, INAAT는 열 사이클러 없이 작동합니다. 따라서 이 기술은 더 빠르고 사용하기 쉽고 휴대가 가능합니다. 유전 물질을 빠르고 쉽게 검출할 수 있기 때문에 INAAT는 기존의 실험실 이외의 광범위한 용도에 유용합니다.

INAAT 시장의 확대는 신속하고 분산된 진단 검사, 특히 감염에 대한 수요가 증가함에 따라 이러한 빠르고 간단한 기술의 채택을 뒷받침하고 있기 때문입니다. 또, 새로운 증폭법이나 보다 사용하기 쉬운 기기의 개발 등, 시장에는 기술 혁신의 흐름이 끊임없이 계속되고 있습니다. 이러한 진보로 대규모 중앙검사실부터 현장 검사를 필요로 하는 진료소나 병원에 이르기까지 폭넓은 최종 사용자가 이 기술을 이용하기 쉬워지고 있습니다. 보다 효율적이고 사용하기 쉬운 진단 방법으로의 전환은 시장이 개척되고 있는 주요 요인입니다.

등온 핵산 증폭 기술 시장 보고서, 하이라이트

제품별로 시약 부문은 2024년에 가장 큰 점유율을 차지했습니다. 이는 시약이 소모품으로서의 특성을 가지며, 검사를 수행할 때마다 최종 사용자로부터 지속적이고 반복적인 수요가 발생하기 때문입니다.

기술별로는 LAMP(loop-mediated isothermal amplification) 분야가 2024년 최대 점유율을 차지했습니다. 이점은 간편성, 비용 효과, 복잡한 열 사이클링 장비 없이 다양한 환경에서 사용할 수 있기 때문에 POC(Point of Care) 진단 용도에 이상적입니다.

용도별로, 다양한 병원체의 신속하고 정확한 검출에 대한 지속적인 수요로 인해 감염 진단 부문이 2024년에 가장 큰 점유율을 차지했습니다. 질병의 발생을 통제할 필요성과 공중 보건 모니터링에서 INAAT의 광범위한 사용으로 인해 이 하위 부문은 시장을 독점하고 있습니다.

최종 용도별로는 2024년에 중앙 및 표준 실험실 부문이 최대의 점유율을 차지했습니다. 이는 이러한 시설이 대량의 검사능력을 가지며, 광범위한 질환 및 조사 요구에 대응한 특수한 분자진단 검사를 실시하기 위한 인프라가 확립되어 있기 때문입니다.

지역별로는 북미가 압도적인 점유율을 차지하고 있으며, 그 배경에는 확립된 헬스케어 시스템과 분자진단제에 대한 왕성한 투자가 있습니다. 수많은 주요 기업들이 존재하고 기술 혁신과 새로운 진단 도구의 신속한 도입에 주력하고 있는 것이 이 지역의 주도적 지위에 기여하고 있습니다. 아시아태평양 시장은 건강 관리 인프라 개선, 공중 보건 의식 증가, 환자 수 증가 등의 요인이 겹치고 가장 빠른 속도로 성장하고 있습니다.

등온 핵산 증폭 기술 시장의 주요 기업으로는 Hologic, Inc.; Eiken Chemical Co., Ltd.; Meridian Bioscience, Inc.; QuidelOrtho Corporation; Becton, Dickinson and Company; Abbott Laboratories; Danaher Corporation; Thermo Fisher Scientific; LGC Limited; and bioMerieux S.A.등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 등온 핵산 증폭 기술(INAAT) 세계 시장 분석

  • 시장 현황
  • 등온 핵산 증폭 기술(INAAT) 시장 역학
    • 성장 촉진요인과 기회
      • POC(Point of Care) 진단 수요 증가
      • 감염증의 만연 증가
    • 억제요인과 과제
      • 플랫폼 간 제한된 표준화
  • PESTEL 분석
  • 등온 핵산 증폭 기술(INAAT) 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 등온 핵산 증폭 기술(INAAT) 시장 : 제품별

  • 주요 조사 결과
  • 소개
  • 기기
  • 시약

제6장 세계의 등온 핵산 증폭 기술(INAAT) 시장 : 기술별

  • 주요 조사 결과
  • 소개
  • NASBA
  • HDA
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • 기타

제7장 세계의 등온 핵산 증폭 기술(INAAT) 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 혈액검사
  • 감염증 진단
  • 기타

제8장 세계의 등온 핵산 증폭 기술(INAAT) 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 병원
  • 중앙 및 표준 실험실
  • 기타

제9장 세계의 등온 핵산 증폭 기술(INAAT) 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 등온 핵산 증폭 기술(INAAT) 시장 분석 : 지역, 2020-2034년
  • 북미
    • 북미 : 제품별, 2020-2034년
    • 북미 : 기술별, 2020-2034년
    • 북미 : 용도별, 2020-2034년
    • 북미 : 최종 용도별, 2020-2034년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품별, 2020-2034년
    • 유럽 : 기술별, 2020-2034년
    • 유럽 : 용도별, 2020-2034년
    • 유럽: 최종 용도별, 2020-2034년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 제품별, 2020-2034년
    • 아시아태평양 : 기술별, 2020-2034년
    • 아시아태평양 : 용도별, 2020-2034년
    • 아시아태평양 : 최종 용도별, 2020-2034년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 제품별, 2020-2034년
    • 중동 및 아프리카 : 기술별, 2020-2034년
    • 중동 및 아프리카 : 용도별, 2020-2034년
    • 중동 및 아프리카 : 최종 용도별, 2020-2034년
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품별, 2020-2034년
    • 라틴아메리카 : 기술별, 2020-2034년
    • 라틴아메리카 : 용도별, 2020-2034년
    • 라틴아메리카 : 최종 용도별, 2020-2034년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 프로파일

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • LGC Limited
  • Meridian Bioscience, Inc.
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific
SHW 25.10.22

The global isothermal nucleic acid amplification technologies market size is expected to reach USD 18.04 billion by 2034, according to a new study by Polaris Market Research. The report "Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagent), By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Isothermal nucleic acid amplification technologies, known as INAAT, are a group of molecular biology techniques that create many copies of DNA or RNA at a single, constant temperature. Unlike older methods that require repeated cycles of heating and cooling, INAAT works without a thermal cycler. This makes the technology much faster, simpler to use, and more portable, which is a major advantage for testing in different places. The ability to quickly and easily detect genetic material makes INAAT useful for a wide range of applications outside of traditional laboratory settings.

The INAAT market expansion is attributed to the increasing demand for rapid and decentralized diagnostic testing, particularly for infectious diseases, which pushes the adoption of these fast and simple technologies. The market is also seeing a continuous stream of innovation, with new amplification methods and more user-friendly instruments being developed. These advancements are making the technology more accessible to a wider range of end users, from large central laboratories to clinics and hospitals that need on-site testing. This shift toward more efficient and accessible diagnostics is a significant factor in the market's ongoing development.

Isothermal Nucleic Acid Amplification Technologies Market Report Highlights:

By product, the reagents segment held the largest share in 2024, because of its nature as a consumable, which generates constant and recurring demand from end users with every test performed.

By technology, the loop-mediated isothermal amplification (LAMP) segment held the largest share in 2024. Its dominance is attributed to its simplicity, cost-effectiveness, and ability to be used in various settings without the need for complex thermal cycling equipment, making it ideal for point-of-care diagnostics applications.

By application, the infectious disease diagnostics segment held the largest share in 2024 due to the continuous demand for rapid and accurate detection of various pathogens. The need to control disease outbreaks and the widespread use of INAAT in public health surveillance make this subsegment a dominant force in the market.

In terms of end use, the central and reference laboratories segment held the largest share in 2024. This is because these facilities have the capacity for high-volume testing and the established infrastructure to perform specialized molecular diagnostic tests for a wide range of diseases and research needs.

By region, North America is the dominating region, driven by its well-established healthcare system and strong investments in molecular diagnostics. The presence of numerous key players and a focus on technological innovation and rapid adoption of new diagnostic tools contribute to its leading position. The Asia Pacific market is growing at the fastest pace, driven by a combination of factors including improving healthcare infrastructure, rising public health awareness, and a large patient population.

A few key players in the isothermal nucleic acid amplification technologies market include Hologic, Inc.; Eiken Chemical Co., Ltd.; Meridian Bioscience, Inc.; QuidelOrtho Corporation; Becton, Dickinson and Company; Abbott Laboratories; Danaher Corporation; Thermo Fisher Scientific; LGC Limited; and bioMerieux S.A.

Polaris Market Research has segmented the isothermal nucleic acid amplification technologies market report based on product, technology, application, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Instruments

Reagent

By Technology Outlook (Revenue - USD Billion, 2020-2034)

NASBA

HDA

LAMP

SDA

SPIA

NEAR

TMA

RCA

RPA

SMAP2

Others

By Application Outlook (Revenue - USD Billion, 2020-2034)

Blood Screening

Infectious Disease Diagnostics

Cancer

Others

By End-use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central & Reference Labs

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Insights

  • 4.1. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Market Snapshot
  • 4.2. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Point-of-Care Diagnostics
      • 4.2.1.2. Increasing Prevalence of Infectious Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Standardization Across Platforms
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.4. Reagent
    • 5.4.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Reagent, by Region, 2020-2034 (USD Billion)

6. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
  • 6.3. NASBA
    • 6.3.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by NASBA, by Region, 2020-2034 (USD Billion)
  • 6.4. HDA
    • 6.4.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by HDA, by Region, 2020-2034 (USD Billion)
  • 6.5. LAMP
    • 6.5.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by LAMP, by Region, 2020-2034 (USD Billion)
  • 6.6. SDA
    • 6.6.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by SDA, by Region, 2020-2034 (USD Billion)
  • 6.7. SPIA
    • 6.7.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by SPIA, by Region, 2020-2034 (USD Billion)
  • 6.8. NEAR
    • 6.8.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by NEAR, by Region, 2020-2034 (USD Billion)
  • 6.9. TMA
    • 6.9.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by TMA, by Region, 2020-2034 (USD Billion)
  • 6.10. RCA
    • 6.10.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by RCA, by Region, 2020-2034 (USD Billion)
  • 6.11. RPA
    • 6.11.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by RPA, by Region, 2020-2034 (USD Billion)
  • 6.12. SMAP2
    • 6.12.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by SMAP2, by Region, 2020-2034 (USD Billion)
  • 6.13. Others
    • 6.13.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Blood Screening
    • 7.3.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Blood Screening, by Region, 2020-2034 (USD Billion)
  • 7.4. Infectious Disease Diagnostics
    • 7.4.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Infectious Disease Diagnostics, by Region, 2020-2034 (USD Billion)
  • 7.5. Cancer
    • 7.5.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.4. Central & Reference Labs
    • 8.4.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Central & Reference Labs, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - North America
    • 9.3.1. North America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.3. North America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.3.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - US
      • 9.3.5.1. US: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.3.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Canada
      • 9.3.6.1. Canada: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
  • 9.4. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Europe
    • 9.4.1. Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - UK
      • 9.4.5.1. UK: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - France
      • 9.4.6.1. France: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.7. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Germany
      • 9.4.7.1. Germany: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.8. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Italy
      • 9.4.8.1. Italy: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.9. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Spain
      • 9.4.9.1. Spain: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.10. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Netherlands
      • 9.4.10.1. Netherlands: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.11. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Russia
      • 9.4.11.1. Russia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.12. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
  • 9.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Asia Pacific
    • 9.5.1. Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - China
      • 9.5.5.1. China: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - India
      • 9.5.6.1. India: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.7. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Malaysia
      • 9.5.7.1. Malaysia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.8. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Japan
      • 9.5.8.1. Japan: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.9. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Indonesia
      • 9.5.9.1. Indonesia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.10. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - South Korea
      • 9.5.10.1. South Korea: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.11. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Australia
      • 9.5.11.1. Australia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.12. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
  • 9.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - UAE
      • 9.6.6.1. UAE: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.7. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Israel
      • 9.6.7.1. Israel: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.8. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - South Africa
      • 9.6.8.1. South Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.9. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
  • 9.7. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Latin America
    • 9.7.1. Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.5. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Mexico
      • 9.7.5.1. Mexico: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.6. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Brazil
      • 9.7.6.1. Brazil: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.7. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Argentina
      • 9.7.7.1. Argentina: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.8. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Isothermal Nucleic Acid Amplification Technologies (INAAT) Market, by End-Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Becton, Dickinson and Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. bioMerieux S.A.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eiken Chemical Co., Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Hologic, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. LGC Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Meridian Bioscience, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. QuidelOrtho Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제